Presentation is loading. Please wait.

Presentation is loading. Please wait.

Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:842-857.

Published byHillary Melissa Collins Modified over 9 years ago

Similar presentations

Presentation on theme: "Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:842-857."— Presentation transcript:

1 Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:842-857

2 Characteristics of Included Trials With High Risk of Bias Goran Bjelakovic, et al. JAMA. 2007;297:842-857

3 Characteristics of Included Trials With Low Risk of Bias – Part I Goran Bjelakovic, et al. JAMA. 2007;297:842-857

4 Characteristics of Included Trials With Low Risk of Bias – Part II Goran Bjelakovic, et al. JAMA. 2007;297:842-857

5 Participants and Outcome Measures of Included Trials With High Risk of Bias Goran Bjelakovic, et al. JAMA. 2007;297:842-857

6 Participants and Outcome Measures of Included Trials With Low Risk of Bias P.I Goran Bjelakovic, et al. JAMA. 2007;297:842-857

7 Participants and Outcome Measures of Included Trials With Low Risk of Bias P.II Goran Bjelakovic, et al. JAMA. 2007;297:842-857

8 Intervention Effect of Antioxidant Supplements vs Placebo on Mortality in Trials With Low Risk of Bias Goran Bjelakovic, et al. JAMA. 2007;297:842-857

Download ppt "Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:842-857."

Similar presentations

Supplemental Figure 1 A No. at risk T3 530 483 304 185 50 T2 559 545 373 228 76 T1 540 532 375 208 64.

Supplemental Figure 1 A No. at risk T T T
Flow chart showing number of citations retrieved by individual searches and number of trials included in review Strippoli GF, et al. BMJ 2008 Feb 25 [Epub.

Flow chart showing number of citations retrieved by individual searches and number of trials included in review Strippoli GF, et al. BMJ 2008 Feb 25 [Epub.
Cardiovascular outcome in patients with dysglycemia with daily supplementation of n-3 fatty acids 1 ORIGIN trial (Outcome Reduction with an Initial Glargine.

Cardiovascular outcome in patients with dysglycemia with daily supplementation of n-3 fatty acids 1 ORIGIN trial (Outcome Reduction with an Initial Glargine.
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295: 74-80.

Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295:
ESH 2004 Paris1 Blood Pressure Control by Home Monitoring A Meta-Analysis of Randomised Trials FP Cappuccio, SM Kerry, L Forbes, A Donald Published in:

ESH 2004 Paris1 Blood Pressure Control by Home Monitoring A Meta-Analysis of Randomised Trials FP Cappuccio, SM Kerry, L Forbes, A Donald Published in:
Information Resources for Evidence-Based Medicine A Review 3 rd Year Family Medicine Clerkship - EBM.

Information Resources for Evidence-Based Medicine A Review 3 rd Year Family Medicine Clerkship - EBM.
Edgar R. Miller III et al. Ann Intern Med. 2005; 142 Clinical Trials of Vitamin E Supplementation and Risk for All-Cause Mortality, Ordered by Dosage of.

Edgar R. Miller III et al. Ann Intern Med. 2005; 142 Clinical Trials of Vitamin E Supplementation and Risk for All-Cause Mortality, Ordered by Dosage of.
CONSORT: Consolidated Standards of Reporting Trials Evidence-based, minimum set of recommendations for reporting clinical trials Rennie (JAMA) urged the.

CONSORT: Consolidated Standards of Reporting Trials Evidence-based, minimum set of recommendations for reporting clinical trials Rennie (JAMA) urged the.
Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:1338- 1347.

Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:
Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:2742-53.

Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:
Ho PM, et al. JAMA 2009;301:937-44. Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:937-44.

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
Lancet 373:1765-72, 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.

Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:1548-59.

Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:
Slide Source www.lipidsonline.org Kaplan-Meier Curve of Time to Primary End Point Proportion of Events (%) Pioglitazone Placebo PROactive investigators.

Slide Source Kaplan-Meier Curve of Time to Primary End Point Proportion of Events (%) Pioglitazone Placebo PROactive investigators.
Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:1561-73.

Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:
Flow diagram of study selection process CAB: Commonwealth Agricultural Bureau Ethan M. Balk, et al. Arch Intern Med. 2007;167:21-30.

Flow diagram of study selection process CAB: Commonwealth Agricultural Bureau Ethan M. Balk, et al. Arch Intern Med. 2007;167:21-30.
Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.

Process of study selection F. Sofi, et al. BMJ 2008 Sep 11;337:a1344.
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:306-313.

Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758.

Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:

Similar presentations

Ads by Google